Skip to Main Content
Skip Nav Destination

An international consensus on photodynamic therapy (PDT) for skin cancer was published in 2007 and described aminolevulinic acid (ALA)-based regimens only, as these are now relatively widely approved for skin cancer applications. Including the very first clinical report on PDT for skin cancer from over 100 years ago by von Tappeiner, photosensitizers (PSs) other than ALA-induced protoporphyrin IX have been used for cutaneous malignancies for many decades. This chapter aims to provide an assessment of the current state of these exogenous PSs in the management of skin cancers.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal